Research Spotlight: Exploring Combination Therapy to Improve Outcomes in NF2-Related Schwannomatosis
February 13, 2026
February 13, 2026
BOSTON, Massachusetts, Feb. 13 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Research Spotlight: Exploring Combination Therapy to Improve Outcomes in NF2-Related Schwannomatosis
*
Lei Xu, MD, PhD, of the Steele Laboratories within the Mass General Brigham Cancer Institute, is the senior author of a paper published in Nature Communications, " NKG2D Upregulation Sensitizes Tumors to Combined Anti-PD . . .
* * *
Research Spotlight: Exploring Combination Therapy to Improve Outcomes in NF2-Related Schwannomatosis
*
Lei Xu, MD, PhD, of the Steele Laboratories within the Mass General Brigham Cancer Institute, is the senior author of a paper published in Nature Communications, " NKG2D Upregulation Sensitizes Tumors to Combined Anti-PD . . .